Colorectal Cancer Trial, Recruiting NCT05405673 Sponsor: Chinese University of Hong Kong Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05405673
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled for a planned colonoscopy for colorectal cancer screening, monitoring of previously found polyps, or investigation of symptoms such as anaemia, changes in bowel habits, or abdominal pain
  • People who are 18 years of age or older
  • People who have provided written consent to participate

Who may not be able to join:

  • People for whom a colonoscopy would be medically unsafe, such as those with a perforated bowel, a blocked intestine, or an unstable heart or lung condition
  • People for whom removal of polyps during the procedure would be unsafe, such as those with active bleeding in the digestive tract, or those currently taking blood thinners or certain anti-clotting medications that cannot be paused
  • People already known to have colorectal cancer or polyps who are scheduled for a separate staged treatment procedure
  • People who have previously had part of their colon surgically removed
  • People with a personal history of colorectal cancer
  • People with a personal history of a polyposis syndrome (a condition causing many polyps to grow in the bowel)
  • People with a personal history of inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • People who are pregnant or currently breastfeeding
  • People with serious complex health conditions that place them in a high-risk category for medical procedures (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 6049 0760

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 June 2022
Est. completion
15 June 2025

Where this trial is recruiting

Hong Kong

Primary endpoints

Sensitivity of bacterial gene markers panel (M3); Sensitivity of FIT/FOBT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov